SynthesisIrish journal of medical science2026
Is Mirabegron-the novel beta 3 agonist-effective in patients with heart failure? A systematic review and meta-analysis of efficacy and safety.
Amr Elrosasy et al.PubMed ↗Publisher ↗
No numbers read from the abstract.